Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders
(firmenpresse) - EDMONTON, ALBERTA -- (Marketwired) -- 07/03/13 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or "the Company") announces that all Directors, Edward Taylor, Don Oborowsky, Gilles Gagnon, Glenn Rourke and John Zupancic, were re-elected to serve for another year at its annual meeting of shareholders held on June 20, 2013.
All other matters at the shareholders' meeting, namely the appointment of Auditors and the Re-approval and Ratification of Stock Options Plan, were also approved by shareholders.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. To learn more about Ceapro, visit .
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Ceapro Inc.
Branko Jankovic
Vice President and CFO
780.917.8376 (Edmonton)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.07.2013 - 21:00 Uhr
Sprache: Deutsch
News-ID 275597
Anzahl Zeichen: 0
contact information:
Town:
EDMONTON, ALBERTA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders"
steht unter der journalistisch-redaktionellen Verantwortung von
Ceapro Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
